Tylenol maker shares rebound a day after Trump’s unfounded claims about its safety
Summary
Shares of Kenvue, the company that makes Tylenol, rose sharply after falling the previous day due to claims made by former President Donald Trump. Trump suggested a link between Tylenol and autism, but Kenvue disputed these claims, saying there is no proven connection.Key Facts
- Tylenol is made by Kenvue, a company based in New Jersey.
- Shares of Kenvue fell 7.5% on Monday but regained most of those losses the following day.
- Former President Donald Trump claimed a link between Tylenol and autism, which health experts have largely discredited.
- Kenvue maintains there is no scientific evidence supporting a connection between Tylenol and autism.
- Kenvue was separated from Johnson & Johnson in 2023 to operate independently.
- Aside from Tylenol, Kenvue also makes Band-Aids and Listerine.
- The company has faced and largely dismissed lawsuits regarding Tylenol and autism claims.
- Shares of Kenvue increased by 5% in premarket trading after initial decline.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.